Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Corticosteroids in Severe Influenza Pneumonia
NCT07786662Phase 3Not yet recruiting
- Sponsor
- CHR Metz-Thionville
- Start
- Sep 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza pneumonia comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Hierarchical composite endpoint of all-cause mortality, number of ventilator-free days and number of ICU-free days at day 28. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
influenza pneumonia
Beyond the preview
Go deeper on NCT07786662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07786662.